Natural History and Prognosis of Pediatric Epilepsies With Different Etiology
Condition(s) studied
Study summary
Epilepsy is one of the most common neurological diseases in Italy, affecting about 500,000 people. Pediatric age represents one of the most affected groups with a consequent significant impact on the quality of life of the families involved.
The study aims to monitor the cognitive functions of patients followed at our center in order to determine the main types of pathways and highlight their determinants. The ultimate goal is to define what are the main clinical and instrumental predictors of cognitive function and its variation over time.
Eligibility
Primary outcome measure(s)
- neurodevelopment level — 12 months after entry visit
Evaluate prescholar global development and scholar cognitive level with Griffiths or Weschler scales where applicable according to age.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Rome | Italy | Recruiting |
More Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07588971 on ClinicalTrials.gov ↗ ← All trials in Italy